Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 29, 2015 12:43 PM ET

Biotechnology

Company Overview of Organovo Holdings, Inc.

Company Overview

Organovo Holdings, Inc., an early commercial stage company, focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. It is developing a suite of standardized and three-dimensional human tissues for the preclinical assessment of drug effects, including applications in predictive toxicology, absorption, distribution, metabolism, excretion, and drug metabolism and pharmacokinetics; customized human tissues as living, dynamic models of human biology or disease for use in drug discovery and development; and three-dime...

6275 Nancy Ridge Drive

Suite 110

San Diego, CA 92121

United States

Founded in 2007

80 Employees

Phone:

858-224-1000

Key Executives for Organovo Holdings, Inc.

Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Age: 43
Total Annual Compensation: $469.9K
Chief Financial Officer and Principal Accounting Officer
Age: 65
Total Annual Compensation: $339.6K
Chief Technology Officer and Executive Vice President of Research & Development
Age: 46
Total Annual Compensation: $334.7K
Chief Strategy Officer and Executive Vice President of Pre-Clinical Development
Age: 43
Total Annual Compensation: $315.1K
Executive Vice President of Commercial Operations
Age: 56
Total Annual Compensation: $268.5K
Compensation as of Fiscal Year 2015.

Organovo Holdings, Inc. Key Developments

Organovo Holdings, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 10:15 AM

Organovo Holdings, Inc. Presents at Cantor Fitzgerald's Inaugural Healthcare Conference, Jul-08-2015 10:15 AM. Venue: Le Parker Meridien Hotel, 119 W. 56th Street, New York, NY 10019, United States. Speakers: Keith Murphy, Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee.

Organovo Holdings Seeks Acquisitions

Organovo Holdings, Inc. (AMEX:ONVO) is seeking acquisitions. Organovo has filed a follow-on equity offering, the net proceeds of which will be used for general corporate purposes, including research and development, the development and commercialization of its products, general administrative expenses, license or technology acquisitions, and working capital and capital expenditures.

Organovo Holdings, Inc. Presents at BIO International Convention 2015, Jun-18-2015 02:00 PM

Organovo Holdings, Inc. Presents at BIO International Convention 2015, Jun-18-2015 02:00 PM. Venue: Pennsylvania Convention Center, Philadelphia, Pennsylvania, United States. Speakers: Sharon Collins Presnell, Chief Technology Officer and Executive Vice President of Research & Development.

Similar Private Companies By Industry

Company Name Region
Millennium Biotherapeutics Inc. United States
GyneConcepts Inc. United States
Diagnostic Biochips, Inc. United States
TNI Pharmaceuticals, Inc. United States
Royer Biomedical, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Organovo Holdings, Inc., please visit www.organovo.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.